In addition to c-Src, EGFR is frequently overexpressed in aggressive breast tumors and triple negative breast cancer cell lines, as are a number of downstream components of EGF signaling pathways [42], [43], [44]. Here, EGF is linked to triple-negative breast carcinoma.